Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Therapeutic Drug Carrier Systems
IF: 2.9 5-Year IF: 3.72 SJR: 0.736 SNIP: 0.551 CiteScore™: 2.43

ISSN Print: 0743-4863
ISSN Online: 2162-660X

Volumes:
Volume 36, 2019 Volume 35, 2018 Volume 34, 2017 Volume 33, 2016 Volume 32, 2015 Volume 31, 2014 Volume 30, 2013 Volume 29, 2012 Volume 28, 2011 Volume 27, 2010 Volume 26, 2009 Volume 25, 2008 Volume 24, 2007 Volume 23, 2006 Volume 22, 2005 Volume 21, 2004 Volume 20, 2003 Volume 19, 2002 Volume 18, 2001 Volume 17, 2000 Volume 16, 1999 Volume 15, 1998 Volume 14, 1997 Volume 13, 1996 Volume 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v29.i1.20
pages 65-88

Two Faces of Carbon Nanotube: Toxicities and Pharmaceutical Applications

Neha Gulati
School of Pharmacy, Bharat Institute of Technology, Meerut, UP, India
Himanshu Gupta
Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India

ABSTRACT

In the field of nanotechnology, carbon nanotube (CNT) is gaining importance for the delivery of therapeutic agents and diagnosis of diseases. CNT is emerging as an efficient nanocarrier system with cylindrical nanostructure. Due to its nanoscale dimensions, CNTs have a high cell-penetration quality that allows its use in site-specific targeting. Another aspect of the utilization of CNT lies in its hollow structure through which an active moiety can be delivered in a controlled manner via CNTs' nano channels. Despite these positive aspects of CNT, scientists are still working to improve its biocompatibility and solubility and eliminating toxicity in vivo, which are creating problems with the use of CNTs. Therefore, functionalization becomes an important aspect to be studied because it decreases the toxicity of CNTs and make them nonimmunogenic. In this review, different functionalization techniques of CNTs and their biomedical applications−in particular for cancer therapy to date−are reviewed in detail to present the potential of this nanovector.


Articles with similar content:

Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.34, 2017, issue 1
Danae Garcia-Viacobo, Franklin A. Carrero- Martinez, Estefany I. Medina-Reyes, Yolanda Irasema Chirino
Heparin-Tailored Biopolymeric Nanocarriers in Site-Specific Delivery: A Systematic Review
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.34, 2017, issue 1
Awesh K. Yadav, Rajeev Sharma, Ashish Garg, Vikas Pandey, Vaibhav Patel
Progress in Lipid-Based Nanoparticles for Cancer Therapy
Critical Reviews™ in Oncogenesis, Vol.19, 2014, issue 3-4
Eliahu Heldman, Charles Linder, Sarina Grinberg
Hyaluronate Derivatives in Drug Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.15, 1998, issue 5
Glenn D. Prestwich, Koen P. Vercruysse
Ethosomes: New Prospects in Transdermal Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.20, 2003, issue 1
Biana Godin, Elka Touitou